Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States

被引：0
|
作者：
Mohamed I. Elsaid
You Li
Carolyn Catalano
Carlos D. Minacapelli
Kapil Gupta
Vinod K. Rustgi
机构：
[1] Rutgers Robert Wood Johnson Medical School,Division of Gastroenterology and Hepatology, Department of Medicine
[2] Rutgers Robert Wood Johnson Medical School,Center for Liver Diseases and Liver Masses
来源：
PharmacoEconomics - Open | 2021年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：89 / 100
页数：11
相关论文
共 50 条
  • [41] Economic Burden of Systemic Lupus Erythematosus Flares and Comorbidities in a Commercially Insured Population in the United States
    Narayanan, Siva
    Wilson, Kathleen
    Ogelsby, Alan
    Juneau, Paul
    Durden, Emily
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2013, 55 (11) : 1262 - 1270
  • [42] Economic burden of interstitial lung disease in a commercially insured population with Sjogren syndrome in the United States
    Lee, Tsung-Ying
    Slejko, Julia F.
    Davies-Teye, Bernard Bright
    Onukwugha, Eberechukwu
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (07): : 786 - 794
  • [43] THE PREVALENCE OF CIRRHOSIS IN THE UNITED STATES AMONG COMMERCIALLY INSURED ADULTS 2011-2018
    Mazumder, Nikhilesh
    Stephen, John
    Kang, Raymond
    Aikman, Cassandra
    Parker, Emily D.
    VanWagner, Lisa B.
    Ladner, Daniela P.
    HEPATOLOGY, 2020, 72 : 414A - 414A
  • [44] Predictors ofHealth Plan Disenrollment Among Commercially-Insured Adults in the United States
    Butler, Anne M.
    Todd, Jonathan V.
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 354 - 355
  • [45] Patterns of use of sildenafil among commercially insured adults in the United States: 1998–2002
    T Delate
    V A Simmons
    B R Motheral
    International Journal of Impotence Research, 2004, 16 : 313 - 318
  • [46] REGIONAL VARIATIONS ACROSS THE UNITED STATES IN THE PREVALENCE OF OVERT HEPATIC ENCEPHALOPATHY AND RIFAXIMIN UTILIZATION AMONG COMMERCIALLY AND MEDICARE INSURED ADULTS
    Wong, Robert J.
    Dashputre, Ankur A.
    Gagnon-Sanschagrin, Patrick
    Heimanson, Zeev
    Maitland, Jessica
    Bellefleur, Remi
    Guerin, Annie
    Sikes, Martha
    Bumpass, Brock
    Olujohungbe, Olamide
    Borroto, Danellys
    Joseph, George J.
    HEPATOLOGY, 2023, 78 : S1408 - S1409
  • [47] Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States
    Benedict, Kaitlin
    Beer, Karlyn D.
    Jackson, Brendan R.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (06) : 1003 - 1010
  • [48] The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States
    Wallace, Zachary
    Miles, Gandarvaka
    Smolkina, Ekaterina
    Petruski-Ivleva, Natalia
    Madziva, Duane
    Cook, Claire
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John
    Choi, Hyon
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1425 - 1428
  • [49] Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States
    Krishnarajah, Girishanthy
    Demissie, Kitaw
    Lefebvre, Patrick
    Gaur, Sunanda
    Duh, Mei Sheng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2255 - 2266
  • [50] Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Commercially Insured Patients on Drug Therapy
    Hennum, Liana
    Samiian, Ali
    Khosla, Dhira
    Louis, Elan
    NEUROLOGY, 2023, 100 (17)
12345